Insights

Innovative Product Launches Seqens has recently launched biobased ingredients such as AdvensProtect 2-EHG Green and Caprylyl Glycol, demonstrating their commitment to sustainable and natural solutions. This presents opportunities to collaborate on supply chain, ingredient sourcing, or co-develop new eco-friendly cosmetics and personal care products.

Expanding Market Presence Active participation in global industry events like InCosmetics Asia and PCHI Guangzhou indicates Seqens' focus on growing their footprint in personal care markets across Asia and beyond. Business development efforts can target partnerships and distribution channels in these regions.

Research and Development Focus With 350 scientists and multiple R&D centers, Seqens is heavily invested in innovation for pharmaceutical and specialty ingredients. Sales opportunities exist in providing advanced technological solutions, custom manufacturing, or innovative ingredient development for their pipeline.

Sustainability and Green Initiatives Seqens' collaboration with partners like Holcim for eco-friendly projects and the launch of biobased products highlight a clear focus on sustainability. This opens doors for selling sustainable packaging, green technologies, or eco-conscious raw materials aligned with their initiatives.

Growing Company Profile With a revenue topping $50 million and a sizeable team of over 1,000 employees, Seqens is positioned for further expansion. Business partners can explore opportunities in providing manufacturing equipment, technical support, or scalable ingredient supply to keep pace with their growth trajectory.

SEQENS Tech Stack

SEQENS uses 8 technology products and services including EIA, D2L Brightspace, Data Version Control, and more. Explore SEQENS's tech stack below.

  • EIA
    Advanced Analytics And Data Science
  • D2L Brightspace
    Communication And Collaboration
  • Data Version Control
    Development
  • Nacelle
    E-commerce
  • ADP Workforce Now
    Human Capital Management
  • Microsoft
    Miscellaneous
  • SpendMap
    Sales
  • Yoast SEO
    Search Engines

Media & News

SEQENS's Email Address Formats

SEQENS uses at least 1 format(s):
SEQENS Email FormatsExamplePercentage
First.Last@seqens.comJohn.Doe@seqens.com
88%
FLast@seqens.comJDoe@seqens.com
11%
FMiddleLast@seqens.comJMichaelDoe@seqens.com
1%

Frequently Asked Questions

Where is SEQENS's headquarters located?

Minus sign iconPlus sign icon
SEQENS's main headquarters is located at 21, Chemin de la Sauvegarde Écully, Auvergne-Rhône-Alpes 69130 FR. The company has employees across 4 continents, including EuropeAsiaNorth America.

What is SEQENS's official website and social media links?

Minus sign iconPlus sign icon
SEQENS's official website is seqens.com and has social profiles on LinkedIn.

What is SEQENS's NAICS code?

Minus sign iconPlus sign icon
SEQENS's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does SEQENS have currently?

Minus sign iconPlus sign icon
As of October 2025, SEQENS has approximately 1.3K employees across 4 continents, including EuropeAsiaNorth America. Key team members include Chief Procurement Officer: C. D.Chief Financial Officer: M. D. R.Chief Of Staff - R&d: S. V.. Explore SEQENS's employee directory with LeadIQ.

What industry does SEQENS belong to?

Minus sign iconPlus sign icon
SEQENS operates in the Pharmaceutical Manufacturing industry.

What technology does SEQENS use?

Minus sign iconPlus sign icon
SEQENS's tech stack includes EIAD2L BrightspaceData Version ControlNacelleADP Workforce NowMicrosoftSpendMapYoast SEO.

What is SEQENS's email format?

Minus sign iconPlus sign icon
SEQENS's email format typically follows the pattern of First.Last@seqens.com. Find more SEQENS email formats with LeadIQ.

When was SEQENS founded?

Minus sign iconPlus sign icon
SEQENS was founded in 2003.
SEQENS

SEQENS

Pharmaceutical ManufacturingAuvergne-Rhône-Alpes, France1001-5000 Employees

SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. 

The group generates a revenue of 1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers.

SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.

Section iconCompany Overview

Headquarters
21, Chemin de la Sauvegarde Écully, Auvergne-Rhône-Alpes 69130 FR
Website
seqens.com
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2003
Employees
1001-5000

Section iconFunding & Financials

  • $50M$100M

    SEQENS's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    SEQENS's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.